Fuzhen Qi

1.3k total citations
29 papers, 1.0k citations indexed

About

Fuzhen Qi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Fuzhen Qi has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Fuzhen Qi's work include Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Fuzhen Qi is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Fuzhen Qi collaborates with scholars based in China, United States and Germany. Fuzhen Qi's co-authors include Ming Sun, Yongqian Shu, Mingde Huang, Pei Ma, Wen‐Ming Chen, Wenming Chen, Tongpeng Xu, Erbao Zhang, Rui Xia and Li Yin and has published in prestigious journals such as PLoS ONE, Journal of Hazardous Materials and Molecular Cancer.

In The Last Decade

Fuzhen Qi

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuzhen Qi China 14 808 771 105 98 84 29 1.0k
Zhujiang Zhao China 16 641 0.8× 341 0.4× 45 0.4× 63 0.6× 21 0.3× 26 757
Sherri Kemper United States 10 468 0.6× 304 0.4× 62 0.6× 185 1.9× 149 1.8× 12 637
Bingqing Hui China 20 627 0.8× 612 0.8× 107 1.0× 81 0.8× 15 0.2× 22 953
Junjun Zhao China 16 309 0.4× 231 0.3× 76 0.7× 44 0.4× 27 0.3× 43 587
Yingjun Xie China 11 423 0.5× 366 0.5× 44 0.4× 49 0.5× 25 0.3× 20 623
Xing Yao China 14 365 0.5× 175 0.2× 114 1.1× 59 0.6× 21 0.3× 38 554
Feiling Feng China 15 334 0.4× 278 0.4× 211 2.0× 53 0.5× 65 0.8× 37 628
Eli Raveh Israel 8 766 0.9× 758 1.0× 68 0.6× 97 1.0× 9 0.1× 8 952

Countries citing papers authored by Fuzhen Qi

Since Specialization
Citations

This map shows the geographic impact of Fuzhen Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuzhen Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuzhen Qi more than expected).

Fields of papers citing papers by Fuzhen Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuzhen Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuzhen Qi. The network helps show where Fuzhen Qi may publish in the future.

Co-authorship network of co-authors of Fuzhen Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Fuzhen Qi. A scholar is included among the top collaborators of Fuzhen Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuzhen Qi. Fuzhen Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Wenhua, Yuhan Zhang, Chupeng Hu, et al.. (2025). Streptococcus lutetiensis inhibits CD8+ IL17A+ TRM cells and leads to gastric cancer progression and poor prognosis. npj Precision Oncology. 9(1). 43–43. 2 indexed citations
2.
Fu, Chen-Xi, Qian Xiang, Yifei Wang, et al.. (2024). Antibiotic resistance at environmental multi-media interfaces through integrated genotype and phenotype analysis. Journal of Hazardous Materials. 480. 136160–136160. 2 indexed citations
3.
Qi, Fuzhen, et al.. (2024). Impacts of soil type on the temporal dynamics of antibiotic resistance gene profiles following application of composted manure. Journal of Hazardous Materials. 480. 136372–136372. 4 indexed citations
5.
Liu, Shiqi, et al.. (2021). Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma. Cancer Cell International. 21(1). 107–107. 5 indexed citations
6.
Li, Meng, et al.. (2020). Circ_0004913 sponges miR-1290 and regulates FOXC1 to inhibit the proliferation of hepatocellular carcinoma. Cancer Cell International. 20(1). 4 indexed citations
7.
Chen, Guofeng, Weidi Yu, Jiru Wang, Fuzhen Qi, & Yudong Qiu. (2020). The methods of preoperative biliary drainage for resectable hilar cholangiocarcinoma patients. Medicine. 99(21). e20237–e20237. 12 indexed citations
8.
Xu, Jianbo, Yijun Lu, Qiaoyu Liu, et al.. (2019). Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B. Cancer Letters. 473. 1–12. 33 indexed citations
9.
Song, Yan, et al.. (2018). Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells. Molecular Medicine Reports. 18(2). 2009–2016. 39 indexed citations
10.
Qi, Fuzhen, Xiang-hua Liu, Hao Wu, et al.. (2017). Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. Journal of Hematology & Oncology. 10(1). 48–48. 109 indexed citations
11.
Xu, Jianbo, et al.. (2016). Hepatocellular Carcinoma with Hypersplenic Thrombocytopenia and Situs Inversus Totalis: A Case Report. Chinese Medical Sciences Journal. 31(2). 134–136. 2 indexed citations
12.
Huang, Mingde, Wenming Chen, Fuzhen Qi, et al.. (2015). Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2. Journal of Hematology & Oncology. 8(1). 119 indexed citations
13.
Huang, Mingde, Wenming Chen, Fuzhen Qi, et al.. (2015). Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2. Journal of Hematology & Oncology. 8(1). 50–50. 141 indexed citations
14.
15.
Qi, Fuzhen, Mingde Huang, Yun Pan, et al.. (2014). A Genetic Variant in the Promoter Region of miR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese. PLoS ONE. 9(1). e85394–e85394. 21 indexed citations
16.
Huang, Mingde, Yun Pan, Ji‐Bin Liu, et al.. (2014). A genetic variant at KIF1B predicts clinical outcome of HBV-related hepatocellular carcinoma in Chinese. Cancer Epidemiology. 38(5). 608–612. 4 indexed citations
17.
An, Jiaze, Ji‐Bin Liu, Li Liu, et al.. (2014). A Genetic Variant in Primary miR-378 Is Associated with Risk and Prognosis of Hepatocellular Carcinoma in a Chinese Population. PLoS ONE. 9(4). e93707–e93707. 21 indexed citations
18.
Qi, Fuzhen, et al.. (2012). Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World Journal of Surgical Oncology. 10(1). 163–163. 37 indexed citations
19.
Chen, Xiaofei, Gang Xu, Qingquan Wu, et al.. (2011). Genetic Variation in the NBS1 Gene Is Associated with Hepatic Cancer Risk in a Chinese Population. DNA and Cell Biology. 31(5). 678–682. 20 indexed citations
20.
Xiao, Mang, Fuzhen Qi, Zhongguang Luo, et al.. (2009). Functional polymorphism of cytotoxic T‐lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population. International Journal of Immunogenetics. 37(1). 27–32. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026